IMR Press / EJGO / Volume 41 / Issue 3 / DOI: 10.31083/j.ejgo.2020.03.5181
Open Access Systematic Review
Prognostic value of Foxp3+ regulatory T cells in endometrial cancer: a meta-analysis
Show Less
1 Department of Obstetrics and Gynecology, Punan Hospital of Pudong New District of Shanghai, Shanghai, China
2 Department of Obstetrics and Gynecology, Shanghai Changning Maternity & Infant Health Hospital, Shanghai, China
Eur. J. Gynaecol. Oncol. 2020 , 41(3), 339–342;
Submitted: 22 January 2019 | Accepted: 25 February 2019 | Published: 15 June 2019

Endometrial cancer is the second most common gynecologic cancer globally, and the prognosis of advanced or recurrent endometrial cancer is very poor. Currently, the prognostic value of Forkhead box protein P3 (FoxP3)+ regulatory T cells (Tregs) in endometrial cancer is unclear. This meta-analysis aimed to evaluate prognostic significance of Foxp3+ Tregs in endometrial cancer. The authors searched the literature from databases including PubMed, Cocohrane, and Web of Science, and selected four eligible studies for further analysis. Meta-analysis of the survival data from 869 endometrial cancer patients showed that there were no significant differences in overall survival, disease-free survival, relapse-free survival or disease-specific survival between patients with high levels of Foxp3+ Tregs infiltration, and those with low levels of Foxp3+ Tregs. In summary, this meta-analysis provided systemic evidence that Foxp3+ Tregs infiltration is not significantly associated with the prognosis of patients with endometrial cancer.

Endometrial cancer
Figure 1.
Back to top